{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:58:48Z","timestamp":1775746728437,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s10620-005-2549-1","type":"journal-article","created":{"date-parts":[[2005,3,31]],"date-time":"2005-03-31T14:28:00Z","timestamp":1112279280000},"page":"634-639","source":"Crossref","is-referenced-by-count":34,"title":["High Eradication Rates of Helicobacter pylori Infection with First- and Second-Line Combination of Esomeprazole, Tetracycline, and Metronidazole in Patients Allergic to Penicillin"],"prefix":"10.1007","volume":"50","author":[{"given":"Maribel","family":"Rodr\ufffdguez-Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Salgado-Mercado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos F.","family":"R\ufffdos-Bedoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgardo","family":"Aponte-Rivera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Acisclo M.","family":"Marxuach-Cu\ufffdtara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\ufffd F.","family":"Rodr\ufffdguez-Orengo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Fern\ufffdndez-Carbia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 1","key":"CR1","first-page":"3","volume":"16","author":"MF Go","year":"2002","unstructured":"Go MF: Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 16(Suppl 1):3?15, 2002","journal-title":"Aliment Pharmacol Ther"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1086\/314785","volume":"179","author":"MJ Blaser","year":"1999","unstructured":"Blaser MJ: Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 179:1523?1530, 1999","journal-title":"J Infect Dis"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(90)91301-P","volume":"2","author":"EAJ Rauws","year":"1990","unstructured":"Rauws EAJ, Tytgat GNY: Cure of duodenal ulcer disease associated with eradication of Helicobacter Pylori. Lancet 2:1233?1235, 1990","journal-title":"Lancet"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JCM.27.8.1870-1873.1989","volume":"27","author":"F Megraud","year":"1989","unstructured":"Megraud F, Brassens-Rabbe MP, Denis F: Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 27:1870?1873, 1989","journal-title":"J Clin Microbiol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1462-5822.1999.00018.x","volume":"1","author":"R Zarrilli","year":"1999","unstructured":"Zarrilli R, Ricci V, Romano M: Molecular response of gastric epithelial cells to Helicobacter pylori-induced cell damage. Cell Microbiol 1:93?99, 1999","journal-title":"Cell Microbiol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc703","volume":"2","author":"RM Peek Jr","year":"2002","unstructured":"Peek RM Jr, Blaser MJ: Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nature Rev Cancer 2:28?37, 2002","journal-title":"Nature Rev Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","volume":"272","author":"NIH Consensus Conference","year":"1994","unstructured":"NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 272:65?69, 1994","journal-title":"JAMA"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","volume":"16","author":"P Malfertheiner","year":"2000","unstructured":"Malfertheiner P, Megraud F, O Morain C: Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Concensus Report. Aliment Pharmacol Ther 16:167?180, 2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"CR9","first-page":"S47","volume":"17","author":"JP Gisbert","year":"2001","unstructured":"Gisbert JP, Pajares JM, Racz I: The year in Helicobacter pylori therapy 2001. Curr Opin Gastroenterol 17(Suppl 1):S47?S54, 2001","journal-title":"Curr Opin Gastroenterol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0016-5085(98)70101-5","volume":"115","author":"F Megraud","year":"1998","unstructured":"Megraud F: Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori. Gastroenterology 115:1278?1272, 1998","journal-title":"Gastroenterology"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0016-5085(98)70100-3","volume":"115","author":"DY Graham","year":"1998","unstructured":"Graham DY: Antibiotic resistance in Helicobacter pylori: implications for therapy. Gastroenterology 115:1272?1277, 1998","journal-title":"Gastroenterology"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1046\/j.1365-2036.1999.00530.x","volume":"13","author":"J Huang","year":"1999","unstructured":"Huang J, Hunt RH: The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycicn and amoxicillin or metronidazole. Aliment Pharmacol Ther 13:719?729, 1999","journal-title":"Aliment Pharmacol Ther"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1128\/AAC.46.7.2229-2233.2002","volume":"46","author":"MM Gerrits","year":"2002","unstructured":"Gerrits MM, Schuijffel D, van Zwet AA, Kuipers EJ, Vandenbroucke-Grauls CM, Kusters JG: Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori. Antimicrob Agents Chemother 46:2229?2233, 2002","journal-title":"Antimicrob Agents Chemother"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1128\/AAC.44.11.3203-3205.2000","volume":"44","author":"DH Kwon","year":"2000","unstructured":"Kwon DH, Kim JJ, Lee M, et al.: Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 44:3203?3205, 2000","journal-title":"Antimicrob Agents Chemother"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000007159","volume":"45","author":"MR Iovene","year":"1999","unstructured":"Iovene MR, Romano M, Pilloni AO, et al.: Prevalence of antimicrobial resistance in eighty clinical isolates of Helicobacter pylori. Chemotherapy. 45:8?14, 1999","journal-title":"Chemotherapy"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/jac\/43.4.511","volume":"43","author":"YJ Debets-Ossenkopp","year":"1999","unstructured":"Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG, Vanderbroucke-Grauls CM: Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline and trovafloxacin in the Netherlands. J Antimicrob Chemother 43:511?415, 1999","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"CR17","doi-asserted-by":"crossref","first-page":"A498","DOI":"10.1016\/S0016-5085(00)84113-X","volume":"118","author":"L Laine","year":"2000","unstructured":"Laine L, Fennerty MB, Suchower L, et al.: H. pylori antibiotic resistance, eradication and emergent resistance in U.S. double-blind trials of esomeprazole, clarithromycin, and amoxicillin. Gastroenterology 118(Suppl 2):A498, 2000","journal-title":"Gastroenterology"},{"issue":"6","key":"CR18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-2036.2003.01746.x","volume":"18","author":"M Vergara","year":"2003","unstructured":"Vergara M, Vallve M, Gisbert JP, Calvet X: Meta-analysis: comparative efficacy of different proton-pump inhibitors in triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 18(6):647?654, 2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 4","key":"CR19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2036.16.s4.13.x","volume":"16","author":"L Laine","year":"2002","unstructured":"Laine L: Review article: esomeprazole in the treatment of Helicobacter pylori. Aliment Pharmacol Ther 16(Suppl 4):115?118, 2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"CR20","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/00042737-200112000-00009","volume":"13","author":"Z Tulassay","year":"2001","unstructured":"Tulassay Z, Kryszewski A, Dite P, Kleczkowski D, Rudzinski J, Bartuzi Z, Hasselgren G, Larko A, Wrangstadh M: One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. Eur J Gastroenterol Hepatol 13(12):1457?1465, 2001","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"CR21","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1046\/j.1365-2036.2000.00911.x","volume":"14","author":"S Veldhuyzen Van Zanten","year":"2000","unstructured":"Veldhuyzen Van Zanten S, Lauritsen K, Delchier JC, Labenz J, De Argila CM, Lind T, Treichel HC, Stubberod A, Cockeram A, Hasselgren G, Gothe L, Wrangstadh M, Sinclair P: One-week triple therapy with esomeprazole provides effective eradication of Helicobacter pylori in duodenal ulcer disease. Aliment Pharmacol Ther 14(12):1605?1611, 2000","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"CR22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1046\/j.1365-2036.2003.01554.x","volume":"17","author":"S Veldhuyzen Van Zanten","year":"2003","unstructured":"Veldhuyzen Van Zanten S, Machado S, Lee J: One-week triple therapy with esomeprazole, clarithromycin and metronidazole provides effective eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 17(11):1381?1387, 2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"CR23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2036.2003.01764.x","volume":"18","author":"S Miehlke","year":"2003","unstructured":"Miehlke S, Schneider-Brachert W, Bastlein E, Ebert S, Kirsch C, Haferland C, Buchner M, Neumeyer M, Vieth M, Stolte M, Lehn N, Bayerdorffer E: Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. Aliment Pharmacol Ther 18(8):799?804, 2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"CR24","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1111\/j.1572-0241.2000.03349.x","volume":"95","author":"L Laine","year":"2000","unstructured":"Laine L, Fennerty MB, Osato M, Sugg J, Suchower L, Probst P, Levine JG: Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 95(12):3393?3398, 2000","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"CR25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2036.2003.01401.x","volume":"17","author":"K Murakami","year":"2003","unstructured":"Murakami K, Sato R, Okimoto T, Nasu M, Fujioka T, Kodama M, Kagawa J: Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance. Aliment Pharmacol Ther 17(1):119?123, 2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2036.2002.01173.x","volume":"16","author":"U Peitz","year":"2002","unstructured":"Peitz U, Sulliga M, Wolle K, Leodolter A, Von Arnim U, Kahl S, Stolte M, Borsch G, Labenz J, Malfertheiner P: High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 16(2):315?324, 2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"16","key":"CR27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0025-7753(00)71640-X","volume":"115","author":"JM Baena Diez","year":"2000","unstructured":"Baena Diez JM, Lopez Mompo C, Rams Rams F, Garcia Lareo M, Rosario Hernandez Ibanez M, Teruel Gila J: Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of a combination of omeprazole, clarithromycin and amoxicillin. Med Clin 115(16):617?619, 2000","journal-title":"Med Clin"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2549-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-005-2549-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-005-2549-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T15:44:37Z","timestamp":1586187877000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-005-2549-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["2549"],"URL":"https:\/\/doi.org\/10.1007\/s10620-005-2549-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}